Reports

Ideas That Generate Results

AstraZeneca - Company Analysis

AstraZeneca - Company Analysis

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Nov, 2011| No. of Pages : 35

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 150.00
CD-ROM Mail Delivery
US$ 200.00
Hard Copy Mail Delivery
US$ 200.00
Electronic Access - Multi-User License
US$ 300.00

List of Figures:

Figure 2-1: AstraZeneca - Revenue by Business Division (Million US$), 2009 & 2010
Figure 2-2: AstraZeneca - Revenue by Geographical Distribution (Million US$), 2009 & 2010
Figure 3-1: AstraZeneca - Stock Chart

List of Tables:

Table 1-1: AstraZeneca - Major Mergers & Acquisitions (2006 to 2009)
Table 1-2: AstraZeneca - Ticker Codes at various Stock Exchange
Table 1-3: AstraZeneca - Key Management People
Table 3-1: AstraZeneca - Financial Overview (Million US$), 2010
Table 3-2: AstraZeneca - Breakup of Revenue & Sales (Million US$), 2008-2010
Table 3-3: AstraZeneca - Key Financial Ratios (2008-2010)
Table 3-4: AstraZeneca - Earnings and Income Estimates (Million US$), 2008-2010
Table 5-1: GlaxoSmithKline - Key Financials (Million US$), 2008-2010
Table 5-2: GlaxoSmithKline - SWOT Analysis
Table 5-3: Merck & Co., Inc. - Key Financials (Million US$), 2008-2010
Table 5-4: Merck & Co., Inc. - SWOT Analysis
Table 5-5: Novartis AG - Key Financials (Million US$), 2008-2010
Table 5-6: Novartis AG - SWOT Analysis
Table 5-7: Abbott Laboratories - Key Financials (Million US$), 2008-2010
Table 5-8: Abbott Laboratories - SWOT Analysis

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.